Using PRP and Cord Blood in Treatment of Covid -19

Virus Clinical Trial

Official title:

the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04393415
• Other study ID #: covid -19
• Status: Recruiting
• Phase: N/A
• Start date: May 25, 2020
• Est. completion date: September 1, 2020

Study information

• Verified date: July 2020
• Source: Aljazeera Hospital
• Contact: Mahmoud Alalfy, PhD
• Phone: 01002611058
• Email: mahmoudalalfy[@]ymail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

covid - 19 is a critical viral infection that affects humans

Description:

Covid -19 pandemic started was declared in 2020

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: September 1, 2020
• Est. primary completion date: August 25, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 70 Years

Eligibility

Inclusion Criteria:

• patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion Criteria:

• patients with negative test for covid -19

Related Conditions & MeSH terms

• Virus

Intervention

Combination Product:
• stem cells
giving stem cells to patients with covid - 19

Locations

Country	Name	City	State
Egypt	Aljazeera( Al Gazeera) hospital	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Aljazeera Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the number of patients with positive covid 19 who will improve after receiving stem cells	patients with positive covid 19 who will improve after receiving stem cells	2 weeks